Detalhe da pesquisa
1.
Steering decision making by terminology: oligometastatic versus argometastatic.
Br J Cancer
; 127(4): 587-591, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715637
2.
ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students: 4 Years of Experience (2016-2019).
J Cancer Educ
; 37(4): 1239-1244, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387267
3.
Meta-Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.
Oncologist
; 26(1): e130-e141, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32924198
4.
HIPEC in advanced epithelial ovarian cancer: why is there controversy?
Curr Opin Oncol
; 32(5): 451-458, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32675595
5.
p16, HPV, and Cetuximab: What Is the Evidence?
Oncologist
; 22(7): 811-822, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28526718
6.
Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.
Oncologist
; 22(9): 1056-1066, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533474
7.
Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization.
Oncologist
; 2022 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35962750
8.
Immunotherapy in head and neck cancer: aiming at EXTREME precision.
BMC Med
; 15(1): 110, 2017 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28571578
9.
Human Papillomavirus (HPV): A Criterion for Therapeutic Decision in Squamous Cell Carcinoma of the Head and Neck?
Recent Results Cancer Res
; 206: 137-147, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27699535
10.
The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials.
Int J Gynecol Cancer
; 27(4): 813-818, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28441253
11.
Further clinical interpretation and implications of KEYNOTE-048 findings.
Lancet
; 396(10248): 379, 2020 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32771103
12.
Revisiting EXTREME in the Immuno-Oncology Era: How to Improve Its Outcomes.
Oncologist
; 26(11): 899-901, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34506672
13.
Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma.
BMC Cancer
; 16: 42, 2016 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26817597
14.
Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab.
Eur Arch Otorhinolaryngol
; 273(6): 1629-36, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26044403
15.
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
Lancet Oncol
; 16(5): 583-94, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25892145
16.
Helical tomotherapy in head and neck cancer: a European single-center experience.
Oncologist
; 20(3): 279-90, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25673104
17.
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients.
Breast Cancer Res
; 16(1): R13, 2014 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24467828
18.
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.
Breast Cancer Res
; 16(1): R6, 2014 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24447434
19.
An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group.
Cancer
; 120(3): 390-8, 2014 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24452673
20.
The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein.
BMC Cancer
; 14: 594, 2014 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25128202